Regeneron Pharmaceuticals SG&A Expenses 2010-2024 | REGN
- Regeneron Pharmaceuticals annual sg&a expenses for 2024 were $2.954B, a 12.28% increase from 2023.
- Regeneron Pharmaceuticals annual sg&a expenses for 2023 were $2.631B, a 24.36% increase from 2022.
- Regeneron Pharmaceuticals annual sg&a expenses for 2022 were $2.116B, a 15.95% increase from 2021.